These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21686164)

  • 1. Knockdown of Akt sensitizes osteosarcoma cells to apoptosis induced by cisplatin treatment.
    Zhang G; Li M; Zhu X; Bai Y; Yang C
    Int J Mol Sci; 2011; 12(5):2994-3005. PubMed ID: 21686164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals.
    Song H; Wei M; Liu W; Shen S; Li J; Wang L
    Histol Histopathol; 2018 Jan; 33(1):73-79. PubMed ID: 28287251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA interference targeting slug increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMA.
    Zhang K; Chen D; Wang X; Zhang S; Wang J; Gao Y; Yan B
    Int J Mol Sci; 2011 Jan; 12(1):385-400. PubMed ID: 21339993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function.
    Fraser M; Bai T; Tsang BK
    Int J Cancer; 2008 Feb; 122(3):534-46. PubMed ID: 17918180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling.
    Zhou Q; Hu T; Xu Y
    J Drug Target; 2020 Feb; 28(2):204-211. PubMed ID: 31305159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
    Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
    Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma.
    Zhao G; Cai C; Yang T; Qiu X; Liao B; Li W; Ji Z; Zhao J; Zhao H; Guo M; Ma Q; Xiao C; Fan Q; Ma B
    PLoS One; 2013; 8(1):e53906. PubMed ID: 23372675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.
    Duan L; Perez RE; Hansen M; Gitelis S; Maki CG
    Cancer Biol Ther; 2014; 15(12):1600-12. PubMed ID: 25482935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1.
    Yuan Z; Cao K; Lin C; Li L; Liu HY; Zhao XY; Liu L; Deng HX; Li J; Nie CL; Wei YQ
    Mol Med; 2011; 17(11-12):1262-74. PubMed ID: 21863213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells.
    Zhang W; Li Q; Song C; Lao L
    Tumour Biol; 2015 Apr; 36(4):2531-9. PubMed ID: 25427639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to cisplatin‑induced apoptosis.
    Zhao Z; Tao L; Shen C; Liu B; Yang Z; Tao H
    Int J Mol Med; 2014 Feb; 33(2):271-6. PubMed ID: 24337183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P14ARF sensitizes human osteosarcoma cells to cisplatin-induced apoptosis in a p53-independent manner.
    Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
    Cancer Biol Ther; 2007 Jul; 6(7):1074-80. PubMed ID: 17611411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting XIST induced apoptosis of human osteosarcoma cells by activation of NF-kB/PUMA signal.
    Gao W; Gao J; Chen L; Ren Y; Ma J
    Bioengineered; 2019 Dec; 10(1):261-270. PubMed ID: 31189404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor.
    Davaadelger B; Duan L; Perez RE; Gitelis S; Maki CG
    Oncotarget; 2016 May; 7(19):27511-26. PubMed ID: 27050276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JNK- and Akt-mediated Puma expression in the apoptosis of cisplatin-resistant ovarian cancer cells.
    Zhao Z; Wang J; Tang J; Liu X; Zhong Q; Wang F; Hu W; Yuan Z; Nie C; Wei Y
    Biochem J; 2012 Jun; 444(2):291-301. PubMed ID: 22394200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells.
    Fraser M; Leung BM; Yan X; Dan HC; Cheng JQ; Tsang BK
    Cancer Res; 2003 Nov; 63(21):7081-8. PubMed ID: 14612499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of AKT/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1: A derivative of tetrandrine.
    Zhang YX; Liu XM; Wang J; Li J; Liu Y; Zhang H; Yu XW; Wei N
    Cancer Biol Ther; 2015; 16(6):965-75. PubMed ID: 25893985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma.
    Tsai HC; Huang CY; Su HL; Tang CH
    PLoS One; 2014; 9(3):e90159. PubMed ID: 24637722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ad-PUMA sensitizes ovarian cancer cells to chemotherapeutic agents.
    Luan QC; Sun YR; Han P; Chen Y
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4525-32. PubMed ID: 26698248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
    Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
    Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.